181 related articles for article (PubMed ID: 31729647)
21. Topiroxostat influences circulating lipid concentrations in hyperuricemic patients
.
Tohyo S
Int J Clin Pharmacol Ther; 2019 Nov; 57(11):567-570. PubMed ID: 31496508
[TBL] [Abstract][Full Text] [Related]
22. Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients.
Cicero AFG; Fogacci F; Cincione RI; Tocci G; Borghi C
Med Princ Pract; 2021; 30(2):122-130. PubMed ID: 33040063
[TBL] [Abstract][Full Text] [Related]
23. Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study).
Kato S; Ando M; Mizukoshi T; Nagata T; Katsuno T; Kosugi T; Tsuboi N; Maruyama S
Nagoya J Med Sci; 2016 May; 78(2):135-42. PubMed ID: 27303100
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Clinical Advantage between Topiroxostat and Febuxostat in Hemodialysis Patients.
Mitsuboshi S; Yamada H; Nagai K; Okajima H
Biol Pharm Bull; 2017; 40(9):1463-1467. PubMed ID: 28867729
[TBL] [Abstract][Full Text] [Related]
25. The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.
Kuwabara Y; Yasuno S; Kasahara M; Ueshima K; Nakao K
Clin Exp Nephrol; 2020 May; 24(5):420-426. PubMed ID: 31875936
[TBL] [Abstract][Full Text] [Related]
26. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
27. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
28. Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis.
Tsukamoto S; Okami N; Yamada T; Azushima K; Yamaji T; Kinguchi S; Uneda K; Kanaoka T; Wakui H; Tamura K
Clin Rheumatol; 2022 Mar; 41(3):911-919. PubMed ID: 34642880
[TBL] [Abstract][Full Text] [Related]
29. U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2.
Mori K; Furuhashi M; Tanaka M; Numata K; Hisasue T; Hanawa N; Koyama M; Osanami A; Higashiura Y; Inyaku M; Matsumoto M; Moniwa N; Ohnishi H; Miura T
Hypertens Res; 2021 Jan; 44(1):107-116. PubMed ID: 32792577
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological urate-lowering approaches in chronic kidney disease.
Li X; Liu J; Ma L; Fu P
Eur J Med Chem; 2019 Mar; 166():186-196. PubMed ID: 30769179
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Tanaka A; Shimabukuro M; Okada Y; Sugimoto K; Kurozumi A; Torimoto K; Hirai H; Node K;
Cardiovasc Diabetol; 2020 Jun; 19(1):85. PubMed ID: 32534578
[TBL] [Abstract][Full Text] [Related]
32. Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review.
Tsai CW; Lin SY; Kuo CC; Huang CC
PLoS One; 2017; 12(1):e0170393. PubMed ID: 28107415
[TBL] [Abstract][Full Text] [Related]
33. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.
Russo E; Viazzi F; Pontremoli R; Barbagallo CM; Bombelli M; Casiglia E; Cicero AFG; Cirillo M; Cirillo P; Desideri G; D'Elia L; Ferri C; Galletti F; Gesualdo L; Giannattasio C; Iaccarino G; Leoncini G; Mallamaci F; Maloberti A; Masi S; Mengozzi A; Mazza A; Muiesan ML; Nazzaro P; Palatini P; Parati G; Rattazzi M; Rivasi G; Salvetti M; Tikhonoff V; Tocci G; Ungar A; Verdecchia P; Virdis A; Volpe M; Grassi G; Borghi C;
J Nephrol; 2022 Jan; 35(1):211-221. PubMed ID: 33755930
[TBL] [Abstract][Full Text] [Related]
34. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
35. The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.
Tanaka Y; Hatakeyama S; Tanaka T; Yamamoto H; Narita T; Hamano I; Matsumoto T; Soma O; Okamoto T; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Takahashi I; Nakaji S; Terayama Y; Funyu T; Ohyama C
PLoS One; 2017; 12(7):e0182136. PubMed ID: 28759644
[TBL] [Abstract][Full Text] [Related]
36. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
[TBL] [Abstract][Full Text] [Related]
37. Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease.
Nata N; Ninwisut N; Inkong P; Supasyndh O; Satirapoj B
Sci Rep; 2023 Aug; 13(1):13494. PubMed ID: 37596359
[TBL] [Abstract][Full Text] [Related]
38. Time to target uric acid to retard CKD progression.
Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
[TBL] [Abstract][Full Text] [Related]
39. Uric acid and incident chronic kidney disease in dyslipidemic individuals.
Barkas F; Elisaf M; Liberopoulos E; Kalaitzidis R; Liamis G
Curr Med Res Opin; 2018 Jul; 34(7):1193-1199. PubMed ID: 28836857
[TBL] [Abstract][Full Text] [Related]
40. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Kawamorita Y; Shiraishi T; Tamura Y; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Nakagawa T; Uchida S
Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
